This all looks like we will get a confirmation that Vaxinia does...

This all looks like we will get a confirmation that Vaxinia does the job without ti need for CarT’s. I’m sure the CarT’s will still be used. But Vaxinia looks very much like the real deal. If so this brings fwd a very important “inflection point “. Because we have so much more data than Oncarlytics at this point,.

The very important part of all of this for us as investors, is that even if the market is asleep and misses the importance of this news, we are eyes wide open focussing on the prize. So if the news we are hoping for drops and the market doesn’t respond we will be presented with the most valuable opportunity to buy more shares that are very much derisked.

A chance to go overweight and grab the opportunity with both hands.

Over the years I’ve seen several announcements like this in different biotechs where the price did not move or even dropped . But later sometimes many weeks or even months later the share price exploded.